Drain lymph fluid to reduce inflammation in septic shock
Part of Infections clinical trials.
This study tests whether draining fluid from a chest lymph channel can lower inflammation chemicals (cytokines) in people with septic shock. It’s done using a procedure and aims to see if this helps stabilize the body’s inflammatory response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult age 18–80, in the surgical ICU
- You have a suspected or confirmed serious infection and are on antibiotics
- Your blood pressure is very low despite treatment, and you need medicines (vasopressors) to keep it up
- You must still meet these blood-pressure and treatment needs right before the procedure
- You can safely travel for the procedure window (not too unstable or changing medicines too often)
- You do not have major exclusions like open abdomen, certain clotting problems, or a severe contrast allergy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if giving fewer fluids (other than the fluids to keep blood pressure up) can help people recover from septic shock. It compares a reduced fluid strategy to the usual care in the ICU.
This study tests a simple blood test to measure how your blood vessels leak fluid during septic shock. The results may help doctors give the right amount of fluids to keep you stable.
This study looks at how the body responds to extra fluids in patients with severe infections (sepsis) who are on a breathing machine. It aims to understand how fluids affect blood flow and congestion to improve treatment.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
This study looks at how sepsis (a severe infection) affects the immune system. The goal is to see if certain blood markers can help doctors predict recovery, which could improve the care of future patients with septic shock.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.